§ OBJECTIVE: To describe and compare two age groups' knowledge of medications linked to falls and willingness to change these medications to reduce their fall risk. METHOD: We analyzed data from community-dwelling adults age 55 and older (n = 1812): 855 adults aged 55 to 64 years and 957 older adults (65 and older) who participated in the 2016 summer wave of the ConsumerStyles survey, an annual Web-based survey. The data are weighted to match the US Current Population Survey proportions on nine US Census Bureau demographic characteristics. MEASUREMENTS: Survey respondents were asked about medication use, knowledge of side effects, their willingness to change their medications to reduce fall risk, communication in the previous year about fall risk with their healthcare provider, and their comfort in discussing fall risk with their healthcare provider. All data were weighted to match the 2016 population estimates. Descriptive statistics and χ 2 (p ≤ .05) were used to identify differences between the two age groups. RESULTS: About one-fifth of all respondents reported using at least one class of medication that increases fall risk. Older adults were less likely to report using medications for mood or sadness, less likely to report knowing the side effects of pain medications, and more willing to change their sleep medications compared with their younger counterparts. Among all respondents using these medication classes, less than one-third knew the potential fall-related side effects. However, most of them expressed willingness to change their medication if advised by their healthcare provider. CONCLUSION: Most older adults were unaware of potential fall risks associated with medications prescribed to address pain, difficulty sleeping, mood or sadness, and anxiety-or nervousness-related health issues. However, most were willing to change their medication if recommended by a healthcare provider. J Am Geriatr Soc 67:527-533, 2019.
Key words: older adults; elderly; falls; medications F alls impose a large healthcare burden with more than 3 million adults ages 65 and over (older adults) treated for a fall in an emergency department and more than 850 000 hospitalized in 2016. 1 Among adults ages 55 to 64, falls resulted in over a million emergency department visits and more than 152 000 hospitalizations. 1 About 2600 adults ages 55 to 64 and 29 000 older adults died due to a fall in 2016. 1 The US older adult population is projected to grow by almost 50% between 2016 and 2030, 2 resulting in increased falls and healthcare utilization if more is not done to prevent falls. 3 Multiple risk factors are associated with falls in the aging population, some of which are modifiable such as vestibular disorders, postural hypotension, and use of certain medications, and they can be targeted to reduce falls. 4 In this study, we focused on the use of medications linked to falls. Medications used to treat pain (eg, opioid analgesics), sleep disorders (eg, over-the-counter antihistamines, sedative hypnotics), depression (eg, antidepressants), and anxiety (eg, benzodiazepines) typically affect the central nervous system (CNS active). They can cause side effects such as dizziness, sedation, confusion, blurred vision, and orthostatic hypotension that increase fall risk. 5 Older adults using CNS-active medications are at an increased risk of more pronounced side effects compared with younger adults due to age-related physiologic changes accounting for variability in drug metabolism and decreased drug clearance (ie, slower elimination of the drug from the body leading to prolonged exposure). [6] [7] [8] Additionally, when taken together, CNS-active medications can have a synergistic effect on cognition and physical function. 9 Taking multiple CNS-active medications, known as CNS polypharmacy, is associated with an increased risk of fall injuries and hospitalizations in older adults. The incident rate ratio for hospitalization for falls in older adults on CNS-active medication increased from 1.22 for those on one CNSactive medication to 3.15 for those on five or more. 10 One way to optimize medication use is to evaluate a patient's medications routinely for potential tapering.
11
Tapering or deprescribing is the process of stopping or reducing drugs with the goal of managing polypharmacy and improving health outcomes. 11 Minimizing exposure to CNSactive medications is an important intervention to reduce fall risk in older adults. Previous research showed that stopping or reducing the dose of CNS-active medications can decrease falls by 66% in older adults. 12 Although physician guidelines exist on how to stop or reduce CNS-active medications, 13, 14 tapering can sometimes be challenging.
Patient preferences and willingness to taper medications play a central role in deprescribing. 15 Providers face challenges in tapering medications in older patients because they may have different priorities of health goals or inadequate information on the risks and benefits of certain medications. 16 To our knowledge, there are no studies representative of the US population that explore older adults' willingness to taper medications linked to falls. The objectives of this study were to examine adults ages 55 to 64 and older adults' knowledge and attitudes about medications linked to falls and their willingness to change medications to reduce fall risk. We included adults ages 55 to 64 because they will soon age into a higher risk patient population. Additionally, their knowledge of the risks and benefits of specific medications could influence how they care for an older loved one.
METHODS

ConsumerStyles survey
The data used in this study came from the summer wave of Porter Novelli's 2016 ConsumerStyles survey. The ConsumerStyles survey is built annually from a series of online consumer marketing surveys that gather information on health-related attitudes and behaviors to inform communication and health promotion activities. The summer wave, conducted from June 24 to July 11, 2016, was sent to 6166 potential respondents who had previously completed the spring wave. A total of 4203 adults (≥18 y) completed the survey for a response rate of 68%. Study respondents received an honorarium of $5 for completing the summer wave survey. The summer wave of ConsumerStyles includes a weighting variable that provides a weight for the data to match the US Current Population Survey proportions for nine factors: sex, age, household income, race/ethnicity, household size, education, census region, and metropolitan status, and whether or not the respondent had access to the Internet before joining the panel. 17 For the current study, we restricted the analysis to adults ages 55 to 64 and ages 65 and older (older adults).
Study variables
Information on the following respondent demographics was recorded: age, sex, race/ethnicity, education, marital status, income, employment status, and whether they lived in a metropolitan statistical area or not. The Census Bureau defines a metropolitan statistical area as a geographic region with high population density and close economic ties. Respondents were also asked to report their health status (excellent, very good, good, fair, or poor) and whether they had specific health conditions (such as anxiety, arthritis, chronic pain, depression, or insomnia).
Survey respondents were asked about medication use. First, they were asked about prescription medications: How many prescription medications are you currently taking? and were allowed to input a number between 0 and 99. Then they were asked a series of questions about whether or not they took medications to treat a series of health issues typically treated with CNS medications: 1. Do you take prescription medicine to help you with pain? 2. Do you take either prescription or over-the-counter medicine to help you sleep? 3. Do you take prescription medicine to help with your mood or for sadness? and 4. 'Do you take prescription medicine to help with anxiety or nervousness?'. Individuals who said yes were asked two follow-up questions for each type of medication they reported using: 1. Which, if any, of these medicines have side effects (like sleepiness, light-headedness, or dizziness) that might make you fall? and 2. How likely would you be to change or reduce your medicine if your doctor thought its side effects (like sleepiness, light-headedness, or dizziness) might make you fall? For the second question, respondents could answer on a 4-point Likert scale (very unlikely, somewhat unlikely, somewhat likely, and very likely).
All respondents regardless of reported medication use were asked whether someone had spoken to them about medications linked to falls in the past 12 months. Finally, they were asked with whom they would be comfortable talking to about medications linked to falls. Possible answers to both questions included doctor, pharmacist, nurse, another healthcare provider, family member or caregiver, or no one, with multiple answers allowed. Respondents who reported no prescription medication use and no use of medications to address the selected health issues were excluded from the analysis for the last two questions.
Statistical analysis
All analyses were performed using SPSS Statistics v.23 (SPSS Inc., Chicago, IL). Then χ 2 tests were used to compare the two age groups (55-64 y vs 65+) using α <.05 to determine statistical differences between groups.
RESULTS
The 1812 respondents included 855 adults ages 55 to 64 and 957 older adults. Older adults were more likely to take five or more medications, more likely to report having arthritis, but less likely to report having anxiety and depression compared with adults ages 55 to 64 (Table 1) .
Approximately one-fifth (21.1%) of all respondents in the sample (all adults ≥55 y) reported using medications to treat pain, followed by sleep disorder (17.9%), mood or sadness (10.0%), and anxiety (9.8%) medications (Table 2) . Among those reporting use of a medication class, less than one-third of respondents reported knowledge of fall-related side effects (Table 2) . However, most were willing to change their medication if recommended by their doctor to reduce fall risk ( Figure 1 ). Older adults were less likely to report using mood or sadness medications, less likely to report knowing the side effects of pain medications, and more willing to change their sleep medication compared with their younger counterparts ( Table 2 ). There were no other statistically significant differences between the age groups in knowledge of side effects and willingness to change their medication use.
Among respondents who reported medication use, 85% of adults ages 55 to 64 and 81.9% of older adults reported not talking to anyone in the past 12 months about medications that might make them fall (Figure 2A ). Of the respondents taking one or more prescription medications, more than 80% reported being comfortable talking to their doctor, and approximately 40% reported being comfortable talking to a pharmacist or nurse about medications that may make them fall ( Figure 2B) . A limited number of respondents stated they would not be comfortable discussing medications and fall risk with anyone. The P-value is a comparison between the two age groups adults ages 55 to 64 years and older adults (≥65 y). 
DISCUSSION
In our study, about one-quarter of adults ages 55 to 64 and one-fifth of older adults reported using one of the medications to treat a health issue typically treated with CNS-active medications. However, less than one-third of those who reported use also reported knowledge of potential fallrelated side effects associated with each medication type. Importantly, we found that most respondents would be willing to change a medication that increases fall risk if recommended by a healthcare provider. CNS-active medications such as opioid-receptor agonists, benzodiazepines, sedative hypnotics, and antidepressants have side effects that alter cognition and physical function and are associated with falls and fall recurrence in older adults. 5, 18 Physiologic changes with advancing age may account for variability in drug metabolism and decreased drug clearance, potentially leading to more pronounced adverse drug events in older adults. 6 Provider-driven patient education on medicationrelated side effects and fall risk could encourage patients and providers to work together and optimize medication use.
Older adults were more likely to report using a higher number of medications compared with adults ages 55 to 64. Previous studies showed polypharmacy was independently associated with a significant decline in cognitive and physical capability 19 and increased risk of falls (14% increase in fall risk with the each medication added beyond four medications). 20 Therefore, targeting older adults for tapering unnecessary medication has potential health benefits. Providers who participated in a qualitative study regarding polypharmacy acknowledged a number of factors as potential barriers to tapering. 16, 21 These included their hesitancy to stop medications prescribed by other physicians, patients' strong beliefs in their medications, concerns about the health consequences of stopping certain medications, and the need to follow clinical guidelines that often influence the number of medications needed to manage a disease state. 21 Providers also reported concerns about applying guideline-directed care in older adults due to the difficulty of performing risk stratification for individual patients and balancing the benefits and harms to older patients. 16 Better tools are needed to quantify risks and benefits of medication use in older adults and to give healthcare providers guidance on how to communicate these issues to patients. Tapering of CNS-active medications is feasible and has a clear benefit in reducing risk of falls and injuries in older adults. Stopping CNS-active medications, including benzodiazepines, was shown to be associated with improved cognition, improved psychomotor activity, and a reduction in falls. 22 Moreover, the EMPOWER cluster randomized trial found that pharmacist-driven medication education to patients led to a reduction of benzodiazepine use by 77% without withdrawal symptoms. 23 Healthcare providers can take the initial step by educating patients on the dangers of CNS-active therapies and the health benefits of tapering unnecessary medications while maintaining appropriate care for patient health. Our findings indicate that older adults are willing to change a medication with appropriate provider guidance. This confirms previous reports that patients trust their providers to make decisions about their prescription medications and will discontinue medications at their provider's recommendation. 24, 25 Given patient willingness to discuss fall risk, healthcare providers should routinely initiate the conversation by screening for fall risk, assessing the patient's modifiable fall risk factors, and intervening to reduce risk by using evidence-based strategies including the effective management of medications linked to falls. 15 Falls risk screening and assessment can be conducted and reimbursed as part of the Medicare Annual Wellness Visit. 26 In addition, falls risk screening, including a medication assessment, is a quality measure under the Medicare Access and CHIP Reauthorization ACT (MACRA) that offers value-based reimbursement for services through a Merit-based Incentive Payment System. 26 Furthermore, the Centers for Disease Control and Prevention developed the Stopping Elderly Accidents, Deaths, and Injuries (STEADI) initiative, based on the American and British Geriatrics Societies' clinical practice guidelines, to provide tools and resources to assist healthcare providers with fall prevention. 27 Resources related to medication management include the Screen, Assess, Facilitate, and Educate approach, highlighting Only respondents reporting use of medication class per health condition were included. steps for a targeted medication review, and the Medications Linked to Falls fact sheet, providing guidance on managing high-risk medications in older adults (www.CDC.GOV/ STEADI). With quality measures in place and resources available, providers are incentivized and well equipped to engage in fall-risk screenings including medication assessment. Documenting any attempt to taper medications (including complete cessation or dose reduction) of fall-risk increasing drugs or rationale for why tapering is not warranted enables evaluation of the impact of medication management on falls and can help justify medication management as an effective strategy. Given the complexity of falls as a geriatric syndrome, these efforts must continue long term to implement a fall-risk reduction strategy.
Patient-engaged conversations on tapering with healthcare providers were associated with increased patient knowledge and information seeking behaviors about medicationrelated harms and openness to tapering potentially harmful medications. 28 The Patient Activation Measure (PAM), developed at the University of Oregon, can measure patients' ability to manage their own health by assessing knowledge, skill, and level of confidence to manage their own health. 29, 30 This measure can be used to tailor individual patient interventions to reduce medication harms and adverse events. Previous studies show that patients with higher scores on PAM are more likely to engage in preventive behaviors, adhere to treatment regimens, and obtain regular healthcare screenings. 29, 31 Highly activated patients are more likely to have better health outcomes and lower healthcare costs due to the reduced need for hospitalizations and emergency department visits as compared with less activated patients. [31] [32] [33] Our study has limitations. First, the sampling approach used by ConsumerStyles is not random. The data set is weighted to be representative of the US population based on selected factors only; nonetheless, research comparing consumer panel data with national population probability sampling data supports the use of ConsumerStyles data. 34 Second, medication use was self-reported and may be underestimated due to the social desirability bias of underreporting CNS-active medications. 35 Third, knowledge of medication side effects and attitude toward medication stopping or tapering was also self-reported and may have been overestimated. Finally, our analyses combined all older adults age 65 and older as one group due to a small sample size in older ages. Future studies are needed to explore willingness to change In the past 12 months, who has talked to you about medicines that might make you fall? a 55-64 65+ Figure 2 . Provider-patient communication on medicines linked to falls by provider type (Source: ConsumerStyles 2016). Respondents reporting no prescription medication use and no use of medications to address selected health issues were excluded (total unweighted count = 1417; age 55-64 n = 610; age ≥65 n = 807). A, Respondents reported previous communication with provider about medicines that may increase fall risk. B, Respondents reported to whom they would be comfortable talking.
a Categories are not mutually exclusive.
b Estimate is unstable due to small sample size (unweighted n < 20).
medications linked to falls among older adults in the oldest age categories (75-84 y and ≥85 y).
In conclusion, with the exception of knowledge of the side effects of pain medications and reported willingness to change sleep medications, both age groups reported similar knowledge and attitudes. Most older adults are unaware of the fall risks associated with medications used for certain health issues including pain, difficulty sleeping, mood or sadness, anxiety or nervousness, but they are willing to change medication if a healthcare provider communicates the risk. Patient and provider awareness about fall-risk increasing drugs, including CNS-active medications, and guidance on tapering and medication management may help lower the risk of adverse drug events, falls, injuries, and deaths.
